Type-2-Diabetes Alters CSF but Not Plasma Metabolomic and AD Risk Profiles in Vervet Monkeys

Epidemiological studies suggest that individuals with type 2 diabetes (T2D) have a twofold to fourfold increased risk for developing Alzheimer’s disease (AD), however, the exact mechanisms linking the two diseases are unknown. In both conditions, the majority of pathophysiological changes, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavanagh, Kylie, Day, Stephen M., Pait, Morgan C., Mortiz, William R., Newgard, Christopher B., Ilkayeva, Olga, Mcclain, Donald A., Macauley, Shannon L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722201/
https://www.ncbi.nlm.nih.gov/pubmed/31555072
http://dx.doi.org/10.3389/fnins.2019.00843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722201/
https://www.ncbi.nlm.nih.gov/pubmed/31555072
http://dx.doi.org/10.3389/fnins.2019.00843

Ejemplares similares